Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.

Dellon ES, Sheikh A, Speck O, Woodward K, Whitlow AB, Hores JM, Ivanovic M, Chau A, Woosley JT, Madanick RD, Orlando RC, Shaheen NJ.

Gastroenterology. 2012 Aug;143(2):321-4.e1. doi: 10.1053/j.gastro.2012.04.049. Epub 2012 May 3.

2.

Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.

Rubinstein E, Lee JJ, Fried A, Logvinenko T, Ngo P, McDonald D, Hait EJ.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):317-20. doi: 10.1097/MPG.0000000000000436.

PMID:
24821535
3.

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.

Dohil R, Newbury R, Fox L, Bastian J, Aceves S.

Gastroenterology. 2010 Aug;139(2):418-29. doi: 10.1053/j.gastro.2010.05.001. Epub 2010 May 7.

PMID:
20457157
4.

Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.

Gupta SK, Vitanza JM, Collins MH.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):66-76.e3. doi: 10.1016/j.cgh.2014.05.021. Epub 2014 Jun 4.

PMID:
24907502
5.

Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer A, Simon HU.

Clin Gastroenterol Hepatol. 2011 May;9(5):400-9.e1. doi: 10.1016/j.cgh.2011.01.017. Epub 2011 Jan 28.

PMID:
21277394
6.

Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.

Schlag C, Pfefferkorn S, Brockow K, Haller B, Slotta-Huspenia J, Schulz S, von Werder A, Ring J, Schmid RM, Bajbouj M.

J Clin Gastroenterol. 2014 Aug;48(7):600-6. doi: 10.1097/01.mcg.0000436439.67768.8d.

PMID:
24177377
7.

Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.

Schlag C, Miehlke S, Heiseke A, Brockow K, Krug A, von Arnim U, Straumann A, Vieth M, Bussmann C, Mueller R, Greinwald R, Bajbouj M.

Aliment Pharmacol Ther. 2015 Nov;42(9):1122-30. doi: 10.1111/apt.13386. Epub 2015 Aug 27.

PMID:
26314389
8.

Eosinophilic esophagitis: treatment with oral viscous budesonide.

Zur E.

Int J Pharm Compd. 2012 Jul-Aug;16(4):288-93. Review.

PMID:
23050387
9.

Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.

von Arnim U, Malfertheiner P.

Dig Dis. 2014;32(1-2):126-9. doi: 10.1159/000357089. Epub 2014 Feb 28. Review.

PMID:
24603395
10.

Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Kagalwalla AF, Akhtar N, Woodruff SA, Rea BA, Masterson JC, Mukkada V, Parashette KR, Du J, Fillon S, Protheroe CA, Lee JJ, Amsden K, Melin-Aldana H, Capocelli KE, Furuta GT, Ackerman SJ.

J Allergy Clin Immunol. 2012 May;129(5):1387-1396.e7. doi: 10.1016/j.jaci.2012.03.005. Epub 2012 Apr 1.

11.

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS.

Gastroenterology. 2011 Nov;141(5):1593-604. doi: 10.1053/j.gastro.2011.07.044. Epub 2011 Aug 9.

PMID:
21835135
12.

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

Kuchen T, Straumann A, Safroneeva E, Romero Y, Bussmann C, Vavricka S, Netzer P, Reinhard A, Portmann S, Schoepfer AM.

Allergy. 2014 Sep;69(9):1248-54. doi: 10.1111/all.12455. Epub 2014 Jul 3.

PMID:
24894658
13.

Mucosal cytokine profiles in paediatric eosinophilic oesophagitis: a case-control study.

Romano C, Chiaro A, Lucarelli S, Santarelli C, Cucchiara S, Guadagnini T, Miele E, Di Nardo G.

Dig Liver Dis. 2014 Jul;46(7):590-5. doi: 10.1016/j.dld.2014.03.003. Epub 2014 Apr 3.

PMID:
24704289
14.

Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes.

Dilger K, Lopez-Lazaro L, Marx C, Bussmann C, Straumann A.

Digestion. 2013;87(2):110-7. doi: 10.1159/000346403. Epub 2013 Jan 25.

PMID:
23364258
15.

A Randomized Controlled Comparison of Esophageal Clearance Times of Oral Budesonide Preparations.

Hefner JN, Howard RS, Massey R, Valencia M, Stocker DJ, Philla KQ, Goldman MD, Nylund CM, Min SB.

Dig Dis Sci. 2016 Feb 26. [Epub ahead of print]

PMID:
26921083
16.

Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Dellon ES, Chen X, Miller CR, Woosley JT, Shaheen NJ.

Am J Gastroenterol. 2012 Oct;107(10):1503-11. doi: 10.1038/ajg.2012.202. Epub 2012 Jul 10.

17.

Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.

Dellon ES, Rusin S, Gebhart JH, Covey S, Higgins LL, Beitia R, Speck O, Woodward K, Woosley JT, Shaheen NJ.

Am J Gastroenterol. 2015 Jun;110(6):821-7. doi: 10.1038/ajg.2015.57. Epub 2015 Mar 17.

PMID:
25781367
18.

Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.

Lucendo AJ, De Rezende LC, Jiménez-Contreras S, Yagüe-Compadre JL, González-Cervera J, Mota-Huertas T, Guagnozzi D, Angueira T, González-Castillo S, Arias A.

Dig Dis Sci. 2011 Dec;56(12):3551-8. doi: 10.1007/s10620-011-1775-y. Epub 2011 Jun 15.

PMID:
21674173
19.

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.

Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH.

Allergy. 2010 Jan;65(1):109-16. doi: 10.1111/j.1398-9995.2009.02142.x. Epub 2009 Oct 1.

20.

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.

Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, Bussmann C, Beglinger C, Schoepfer A, Simon HU.

Gastroenterology. 2010 Nov;139(5):1526-37, 1537.e1. doi: 10.1053/j.gastro.2010.07.048. Epub 2010 Aug 1.

PMID:
20682320
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk